HFCWO in Hospitalized Asthmatic Children

Completed · Not applicable

Conditions studied: Bronchial Asthma, Asthma, Status Asthmaticus

In brief

To determine whether or not high frequency chest wall oscillation (in the form of the VestTM) is superior to regular asthma therapy in the management of children hospitalized with moderate to severe asthma.

Key facts

Study ID

NCT00722020

Run by

Hill-Rom

People needed

43

Starts

2008-07-01

Expected to finish

2010-07-01

Last updated by the study team

2017-08-07

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any pediatric patient between the ages of 18 months and 18 years admitted to Winthrop University Hospital's pediatric floor or intensive care unit with a diagnosis of asthma or reactive airway disease

You may not qualify if…

• Patients with chronic, comorbid respiratory conditions (e.g., cerebral palsy, cystic fibrosis)
• Those who regularly use HFCWO
• Any patient exhibiting an absolute contraindication to HFCWO therapy
• Absolute contraindications to using HFCWO include head and neck injury prior to stabilization, and active hemorrhage with hemodynamic instability

Where it is running

• Winthrop University Hospital, Winthrop Pediatric Associates — Long Island City, New York, United States
• Winthrop University Hospital — Long Island City, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.